Bioventus
Carl Flannery has a significant work experience in the field of scientific affairs. Carl started as an Associate Scientific Director at Genzyme, a Sanofi company in 2012, and worked there until 2015. In 2015, they joined Bioventus as a Director of Scientific Affairs, and later became the Senior Director of Scientific Affairs in January 2020. Carl holds expertise in scientific affairs and has played a crucial role in both companies.
Carl Flannery earned a Bachelor's Degree in Applied Biology from Brunel University London from 1980 to 1984. Carl then went on to obtain a Doctor of Philosophy (Ph.D.) in Medical Sciences from the University of South Florida from 1992 to 1995.
Bioventus
4 followers
Bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus accomplishes this with its orthobiologic solutions for musculoskeletal healing and regeneration that engage and enhance the body’s healing process. The company has products for bone healing, bone graft and knee osteoarthritis. Established in 2012, Bioventus is privately held and headquartered in Durham, NC. The company has more than 700 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN and Toronto, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world, and generates $300 million dollars in yearly revenue.